GERRATANA, Elisabetta
GERRATANA, Elisabetta
Dipartimento di Medicina Clinica e Sperimentale
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors
2018-01-01 Atzeni, F.; Talotta, R.; Nucera, V.; Marino, F.; Gerratana, E.; Sangari, D.; Masala, I. F.; Sarzi-Puttini, P.
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
2021-01-01 Erre, Gian Luca; Sebastiani, Marco; Manfredi, Andreina; Gerratana, Elisabetta; Atzeni, Fabiola; Passiu, Giuseppe; Mangoni, Arduino A
Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound
2020-01-01 Fiorenza, Alessia; Bonitta, Gianluca; Gerratana, Elisabetta; Marino, Francesca; Sarzi-Puttini, Piercarlo; Salaffi, Fausto; Atzeni, Fabiola
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis
2019-01-01 Marino, Francesca; Nucera, Valeria; Gerratana, Elisabetta; Fiorenza, Alessia; Sangari, Donatella; Miceli, Gianfranco; Masala, Ignazio Francesco; Atzeni, Fabiola
Concerns about the safety of anti-TNF agents when treating rheumatic diseases
2020-01-01 Atzeni, Fabiola; Nucera, Valeria; Gerratana, Elisabetta; Cirillo, Mariateresa; Marino, Francesca; Miceli, Gianfranco; Sangari, Donatella; Boccassini, Laura; Masala, Ignazio Francesco
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data
2021-01-01 Atzeni, Fabiola; Gerratana, Elisabetta; Bongiovanni, Sara; Talotta, Rossella; Miceli, Gianfranco; Salaffi, Fausto; Sarzi-Puttini, Piercarlo
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
2021-01-01 Nucera, Valeria; Gerratana, Elisabetta; Giallanza, Manuela; La Corte, Laura; Sangari, Donatella; Atzeni, Fabiola
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
2021-01-01 Adami, G.; Gerratana, E.; Atzeni, F.; Benini, C.; Vantaggiato, E.; Rotta, D.; Idolazzi, L.; Rossini, M.; Gatti, D.; Fassio, A.
Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
2021-01-01 Atzeni, Fabiola; Gerratana, Elisabetta; Francesco Masala, Ignazio; Bongiovanni, Sara; Sarzi-Puttini, Piercarlo; Rodríguez-Carrio, Javier
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
2020-01-01 Barbieri, Maria Antonietta; Cicala, Giuseppe; Cutroneo, Paola Maria; Gerratana, Elisabetta; Palleria, Caterina; DE SARRO, Caterina; Vero, Ada; Iannone, Luigi; Manti, Antonia; Russo, Emilio; De Sarro, Giovambattista; Atzeni, Fabiola; Spina, Edoardo
The effect of drugs used in rheumatology for treating SARS-CoV2 infection
2021-01-01 Atzeni, Fabiola; Gerratana, Elisabetta; Giallanza, Manuela; La Corte, Laura; Nucera, Valeria; Miceli, Gianfranco; Sangari, Donatella; Masala, Ignazio Francesco
The rheumatology drugs for COVID-19 management: Which and when?
2021-01-01 Atzeni, F.; Masala, I. F.; Rodriguez-Carrio, J.; Rios-Garces, R.; Gerratana, E.; Corte, L. L.; Giallanza, M.; Nucera, V.; Riva, A.; Espinosa, G.; Cervera, R.
Toxicological considerations in the treatment of axial spondylo-arthritis
2020-01-01 Marino, Francesca; D'Angelo, Salvatore; Masala, Ignazio Francesco; Gerratana, Elisabetta; Nucera, Valeria; La Corte, Laura; Giallanza, Manuela; Sarzi-Puttini, Piercarlo; Atzeni, Fabiola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors | 1-gen-2018 | Atzeni, F.; Talotta, R.; Nucera, V.; Marino, F.; Gerratana, E.; Sangari, D.; Masala, I. F.; Sarzi-Puttini, P. | |
| Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications | 1-gen-2021 | Erre, Gian Luca; Sebastiani, Marco; Manfredi, Andreina; Gerratana, Elisabetta; Atzeni, Fabiola; Passiu, Giuseppe; Mangoni, Arduino A | |
| Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound | 1-gen-2020 | Fiorenza, Alessia; Bonitta, Gianluca; Gerratana, Elisabetta; Marino, Francesca; Sarzi-Puttini, Piercarlo; Salaffi, Fausto; Atzeni, Fabiola | |
| Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis | 1-gen-2019 | Marino, Francesca; Nucera, Valeria; Gerratana, Elisabetta; Fiorenza, Alessia; Sangari, Donatella; Miceli, Gianfranco; Masala, Ignazio Francesco; Atzeni, Fabiola | |
| Concerns about the safety of anti-TNF agents when treating rheumatic diseases | 1-gen-2020 | Atzeni, Fabiola; Nucera, Valeria; Gerratana, Elisabetta; Cirillo, Mariateresa; Marino, Francesca; Miceli, Gianfranco; Sangari, Donatella; Boccassini, Laura; Masala, Ignazio Francesco | |
| Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data | 1-gen-2021 | Atzeni, Fabiola; Gerratana, Elisabetta; Bongiovanni, Sara; Talotta, Rossella; Miceli, Gianfranco; Salaffi, Fausto; Sarzi-Puttini, Piercarlo | |
| Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases | 1-gen-2021 | Nucera, Valeria; Gerratana, Elisabetta; Giallanza, Manuela; La Corte, Laura; Sangari, Donatella; Atzeni, Fabiola | |
| Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? | 1-gen-2021 | Adami, G.; Gerratana, E.; Atzeni, F.; Benini, C.; Vantaggiato, E.; Rotta, D.; Idolazzi, L.; Rossini, M.; Gatti, D.; Fassio, A. | |
| Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs? | 1-gen-2021 | Atzeni, Fabiola; Gerratana, Elisabetta; Francesco Masala, Ignazio; Bongiovanni, Sara; Sarzi-Puttini, Piercarlo; Rodríguez-Carrio, Javier | |
| Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study | 1-gen-2020 | Barbieri, Maria Antonietta; Cicala, Giuseppe; Cutroneo, Paola Maria; Gerratana, Elisabetta; Palleria, Caterina; DE SARRO, Caterina; Vero, Ada; Iannone, Luigi; Manti, Antonia; Russo, Emilio; De Sarro, Giovambattista; Atzeni, Fabiola; Spina, Edoardo | |
| The effect of drugs used in rheumatology for treating SARS-CoV2 infection | 1-gen-2021 | Atzeni, Fabiola; Gerratana, Elisabetta; Giallanza, Manuela; La Corte, Laura; Nucera, Valeria; Miceli, Gianfranco; Sangari, Donatella; Masala, Ignazio Francesco | |
| The rheumatology drugs for COVID-19 management: Which and when? | 1-gen-2021 | Atzeni, F.; Masala, I. F.; Rodriguez-Carrio, J.; Rios-Garces, R.; Gerratana, E.; Corte, L. L.; Giallanza, M.; Nucera, V.; Riva, A.; Espinosa, G.; Cervera, R. | |
| Toxicological considerations in the treatment of axial spondylo-arthritis | 1-gen-2020 | Marino, Francesca; D'Angelo, Salvatore; Masala, Ignazio Francesco; Gerratana, Elisabetta; Nucera, Valeria; La Corte, Laura; Giallanza, Manuela; Sarzi-Puttini, Piercarlo; Atzeni, Fabiola |